IceCure says SIO seeks NCCN breast cancer guideline backing for cryoablation

The petition asks NCCN to consider percutaneous cryoablation as a Category 2B option for selected low-risk, early-stage breast cancer patients, including some ages 50-69 who cannot or do not want surgery.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.